NCT02302456View on ClinicalTrials.gov

Tranexamic Acid for Preventing Postpartum Haemorrhage Following a Vaginal Delivery

PHASE3CompletedINTERVENTIONAL
Enrollment

4,079

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

April 30, 2017

Conditions
Immediate Postpartum Hemorrhage
Interventions
DRUG

Tranexamic Acid

Intravenous administration of a 10 mL solution containing 1g of tranexamic acid within 2 minutes of birth and routine prophylactic IV injection of oxytocin

DRUG

Placebo

Intravenous administration of 10 mL of 0.9% sodium chloride solution within 2 minutes of birth and routine prophylactic IV injection of oxytocin

Trial Locations (1)

49933

Angers University Hospital, Angers

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Angers

OTHER_GOV

NCT02302456 - Tranexamic Acid for Preventing Postpartum Haemorrhage Following a Vaginal Delivery | Biotech Hunter | Biotech Hunter